Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-25-000002

Chief Financial Officer sold 3,594 shares at $15.00 ($53,910)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goeltz II Robert C. Chief Financial Officer 2024-12-31 Sale 10b5-1 −3,594 $15.00 $53,910 60,138 D
Open-market sales · 3,594 sh · avg $15.00 · $53,910
Loading xslF345X05/wk-form4_1735938476.xml…